The MHealth market is a mature market, with the acquisitions since 2017 indicate maturity: they increased steadily until 2016, but settled from 2017 onwards indicating the beginning of the maturity stage of the sector.
Before looking at the main investors in the sector, we explain what MHealth is. MHealth or mobile health refers to the use of mobile technology to manage people's health and well-being. It is commonly used with the support of mobile devices, such as PDAs, mobile phones, tablets or patient monitoring devices, among others. One of the most well known investments was in 2014 when Apple bought Glimpse, a personal health data platform where users or patients can collect, personalise and share an image of their health data.
StartUp Health is a Venture Capital focused on early-stage digital health investments in the US, Asia and Europe. Its health investments are in: health Moonshots, access to care, cost to zero, disease prevention and cures, ending cancer, women's health, children's health, nutrition and fitness, brain health, mental health and happiness, addiction prevention and mitigation, healthy longevity and pandemic response.
In September 2020, StartUp Health raised $ 500,000 in a funding round to invest in health transformers to achieve health triggers.
Unlike StartUp Health, Samsung Next is not focused solely on MHealth investments. Samsung NEXT invests in technology companies in different areas: blockchain, digital health, IoT... Always with the aim of thriving and adding to Samsung's software and services market.
Among the companies in which Samsung NEXT has invested are: Figure 1a platform that connects healthcare professionals around the world to view, discuss and share medical cases and other information. Cylerawhich offers its users information and personalised medical care.
EN 
ES